• Prostate Cancer

    Minimizing Prostate Cancer Overdiagnosis without Missing the Target: Harnessing Fusion Technology to Overcome Limitations of PSA

    by  • November 11, 2014 • Active Surveillance, Cancer Screening, Prostate Cancer

    by David Y.T. Chen, MD, FACS, and Alexander Kutikov, MD, FACS In 2012, the United States Preventative Services Task Force (USPSTF) made the highly publicized and controversial recommendation advising against routine screening for prostate cancer with the prostate specific antigen (PSA) blood test. Even though prostate cancer is the most common cancer in US...

    Read more →

    Managing Erectile Dysfunction after Prostate Surgery

    by  • August 4, 2014 • Coping with Cancer, Prostate Cancer

    A common sexual side effect men face after prostate cancer surgery is erectile dysfunction (the inability to achieve or sustain an erection suitable for sexual intercourse often caused by medications, chronic illnesses or poor blood flow to the penis). It is important to note that this condition can be managed through various treatment options....

    Read more →

    Robotic Salvage Prostatectomy: An Option for Men Whose Prostate Cancer has Returned after Initial Radiation Treatment

    by  • March 29, 2014 • Prostate Cancer, Robotic Surgery, Surgery

    Prostate cancer can be treated with either surgery or radiation therapy. For men who were initially treated with radiation therapy alone, prostate cancer can return in up to 40-50 percent of cases (Zelefsky et al). Prostate cancer recurrence after failed radiation treatment can significantly impact a patient’s quality of life and cause considerable morbidity...

    Read more →

    Prostate Cancer Survivorship Study is Now Open – Enroll Now!

    by  • March 8, 2014 • Clinical Trials, Coping with Cancer, Prostate Cancer

    I and my research staff at Fox Chase Cancer Center have recently launched a new study called PROGRESS (Prostate Cancer Online Guide& Resources for Electronic Survivorship Service) for men who have completed prostate cancer treatment within the last year. The purpose is to assess a new program designed to help men set wellness goals...

    Read more →

    Can doctors prevent overtreatment for prostate cancer patients?

    by  • August 2, 2013 • Active Surveillance, Cancer Staging, Prostate Cancer

    In a recent article in the Journal of the American Medical Association, entitled, “Overdiagnosis and Overtreatment in Cancer An Opportunity for Improvement,” a group of experts discussed the findings from a National Cancer Institute working group designed to improve the current approach to cancer screening and prevention1. Among their recommendations included a motion to...

    Read more →

    Is Single Port Surgery Right for Me?

    by  • June 27, 2013 • Bladder Cancer, Kidney Cancer, Prostate Cancer, Reconstructive Surgery, Robotic Surgery, Single Port Surgery, Surgery

    Advances in Minimally Invasive Surgery: Over the past twenty years, minimally invasive surgery has been successful in reducing the large scars associated with traditional surgery to a few scars less than one inch in length. As a result, our patients have experienced faster, easier recoveries with less pain and fewer complications.  During the past...

    Read more →

    Protons versus Photons for the Treatment of Prostate Cancer

    by  • June 14, 2013 • Prostate Cancer

    The management of clinically localized prostate cancer, or cancer that has not spread beyond the prostate gland, is complex. There are a number of treatment options, ranging from close observation with frequent reassessment (active surveillance), surgery, and radiation therapy. While each form of active treatment can be effective, all can cause side effects that...

    Read more →

    Should men with prostate cancer receive DEXA screening?

    by  • March 20, 2013 • Cancer Screening, News, Prostate Cancer, Risk Assessment

    Bone mineral density (DEXA) screening among men with prostate cancer: a missed opportunity Prostate cancer is the most common cancer among men in the United States and the second leading cause of cancer death.  The use of androgen-deprivation therapy (ADT), which reduce male hormone levels, or prevent them from reaching the prostate cancer cells,...

    Read more →